drugset / Trial / NCT06059677

Cannabis Consumption and Driving Impairment Assessment on a Closed Course

NCT06059677

Phase 2 Unknown 300 enrolled Bayliss J. Camp, PhD
RandomizedParallel-groupTriple-blindOther

Summary

In a true experiment, roughly 300 volunteer participants will smoke active cannabis, a corresponding placebo, or no substance at all (control). Next, participants will complete a drive test and then be observed by actual California Highway Patrol (CHP) officers who will attempt to classify participants as impaired or unimpaired. CHP Officers will evaluate participants in the context of driving (i.e., while following participants in an actual patrol car), as part of a roadside behavioral assessment (i.e., the Advanced Roadside Impaired Driving Enforcement, or ARIDE, battery, which includes Standardized Field Sobriety Tests, or SFSTs), and as part of a Drug Recognition Expert (DRE) evaluation conducted indoors.

Timeline

Start
2023-10-03
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabis Traditional medicine (herbal / TCM) 89.18 mg Inhaled

Indications

No indication recorded.